Please select a version:
Smarter Collaboration Built In with the new Comment Feature
The new Comment feature lets you easily communicate and align with colleagues without leaving drugTrack. Mention users to notify them instantly, reference specific fields, and add hyperlinks to provide clear, actionable context. By keeping conversations close to the data, this feature reduces back-and-forth and even improves cross-functional workflows.
Simplified Creation of Proposed Marketing Authorisations
You can now create and edit multiple Proposed Marketing Authorisations and their related Regulatory Activities in one step. The "Create proposal" option allows you to prepare changes without directly editing records. This makes bulk editing and bulk creation of Marketing Authorisations faster, easier, and more controlled.
RIM features in drugTrack: A More Accessible and Personalized Experience in LORENZ RIM
The latest release brings a refreshed look to the LORENZ RIM web interface with improved accessibility and customization. The Modern Theme is now available in Light and Dark Modes, with updated colors that meet Web Content Accessibility Guideline standards. New options let users adjust contrast, font size, and spacing to suit their visual and working needs. An experimental theme named “Innova” also adds more flexibility with customizable color and shape settings, offering a more tailored experience for you.
RIM features in drugTrack: Boost your productivity through integrated RIM workflows
An enhanced integration between drugTrack and docuBridge enables the linking of applications in docuBridge to Marketing Authorisations in drugTrack, leveraging a central Regulatory Activity to improve RIM workflows. This improvement ensures better data consistency across all functionalities, given that the RA description, RA status, and RA status date are now managed centrally. Additionally, users only need to select the initial sequence of a Regulatory Activity, as all following sequences will be automatically linked to the corresponding Regulatory Activity.